| 000 | 01620 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514211313.0 | ||
| 264 | 0 | _c20050511 | |
| 008 | 200505s 0 0 eng d | ||
| 022 | _a1526-632X | ||
| 024 | 7 |
_a10.1212/wnl.63.10_suppl_4.s30 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSankar, Raman | |
| 245 | 0 | 0 |
_aInitial treatment of epilepsy with antiepileptic drugs: pediatric issues. _h[electronic resource] |
| 260 |
_bNeurology _cNov 2004 |
||
| 300 |
_aS30-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 |
_aAnticonvulsants _xadverse effects |
| 650 | 0 | 4 |
_aAutistic Disorder _xdrug therapy |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aComorbidity |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xcomplications |
| 650 | 0 | 4 |
_aEpilepsy _xclassification |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypercholesterolemia _xchemically induced |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 | _aInsulin Resistance |
| 650 | 0 | 4 |
_aLearning Disabilities _xchemically induced |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMental Disorders _xchemically induced |
| 650 | 0 | 4 |
_aMigraine Disorders _xdrug therapy |
| 650 | 0 | 4 |
_aObesity _xchemically induced |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aRetrospective Studies |
| 773 | 0 |
_tNeurology _gvol. 63 _gno. 10 Suppl 4 _gp. S30-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/wnl.63.10_suppl_4.s30 _zAvailable from publisher's website |
| 999 |
_c15243587 _d15243587 |
||